Diovan (valsartan) to reduce cardiovascular death after a heart attack
November 2005
Health Canada has approved Diovan (valsartan) to reduce cardiovascular death after a heart attack.
This ARB is a good choice for high-risk patients with heart failure or left ventricular dysfunction...who can't tolerate an ACEI.
Diovan seems to work as well as an ACE inhibitor for improving survival and preventing recurrent heart attacks.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote